Health committee  Absolutely; that would be fine.

Health committee  I realize there is limited time so I won't run on, but there are essentially two different kinds of activities that we conduct with regard to medical cannabis.

Health committee  Generally speaking, we don't inspect those kinds of facilities, because that requires entering a person's place of residence, etc., but with regard to the licensed producers—

Health committee  Very good. This doesn't mean we have not gone frequently, for example, with the police services to actually inspect when there are concerns, but we don't do regular, scheduled inspections of people at home.

Health committee  As the minister said, we have new authorities with the Cannabis Act to take action in these kinds of circumstances whenever it is warranted. I cannot say that this will mean, with regard to every individual growing at home, that we would be able to exercise new authorities, but c

Health committee  Well, one thing we try to do is work with municipalities, for example, with the Federation of Canadian Municipalities, to try to provide advice and guidance on how they should approach these matters.

Health committee  I think what I would have to do, Mr. Chair, is I'd be more than happy to get back to the member with a bit more detail on this issue. I will be the first to say that I don't have a granular answer to what standards might exist with regard to odour.

Health committee  To be clear, in some circumstances there are medical devices that remain in the market longer in the U.S. than in Canada. I think the minister has been pretty clear in her public statements. The government feels there's more that can be done in the area of medical devices. The de

Health committee  An expedited process in what respect?

Health committee  It really depends on what the signals are that are coming from the marketplace. Whether it's a drug—

Health committee  When I'm talking about the marketplace, I'm talking about the way it's being used by patients. Whether it's a drug or a medical device, we receive a wide range of information once that product is in the market. It can come from voluntary reports from patients; it can come from th

Health committee  Yes.

Health committee  We have already had one conversation at the level of senior officials with our colleagues in the provinces and territories about this. The minister spoke a little bit about the government's view on this. My understanding is that there is going to be further follow-up at the level

Health committee  Mr. Chair, to reassure the member and all the committee, as a senior official I would echo the views of the minister. This is an absolutely abhorrent practice. If we were aware of these sorts of instances, I can assure you we would be passing that information to the appropriate a

Health committee  Mr. Chair, maybe I would just update and remind the committee that we have been discussing proposals for the modernization of the patented medicine regulations now for about the last two years or so. There was a regulatory proposal that the government tabled a number of months ag